You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

Dash Pharms Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for DASH PHARMS, and what generic and branded alternatives to DASH PHARMS drugs are available?

DASH PHARMS has nineteen approved drugs.



Summary for Dash Pharms
US Patents:0
Tradenames:15
Ingredients:15
NDAs:19

Drugs and US Patents for Dash Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dash Pharms ESCITALOPRAM OXALATE escitalopram oxalate TABLET;ORAL 077550-003 May 14, 2015 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Dash Pharms DISULFIRAM disulfiram TABLET;ORAL 203916-001 Mar 4, 2015 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Dash Pharms RISPERIDONE risperidone TABLET, ORALLY DISINTEGRATING;ORAL 091537-005 Mar 30, 2011 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Dash Pharms Natco SELEGILINE HYDROCHLORIDE selegiline hydrochloride TABLET;ORAL 074866-001 Nov 26, 1997 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.